Clinical Trial 50718

Berlin, NJ 08009


A Phase 2, Multi-center, Randomized, Double-Blind, ParallelGroup, Dose-Finding Study to Assess the Effect of Four Doses of MM-120 for the Treatment of Anxiety Symptoms.

Qualified Participants Must:

• Be 18-74 years old
• Have a BMI of 18-38 mg/kg2
• Be diagnosed with generalized anxiety disorder (GAD)

Qualified Participants May Receive:

  • Up to $1,300 for time and tavel
  • No insurance needed and transportation available

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.